XML 35 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues      
Premiums $ 42,009 $ 42,034 $ 42,235
Universal life and investment-type product policy fees 5,756 5,603 5,603
Net investment income 21,395 17,117 18,868
Other revenues 2,619 1,849 1,842
Net investment gains (losses) 1,529 (110) 444
Net derivative gains (losses) (2,228) 1,349 628
Total revenues 71,080 67,842 69,620
Expenses      
Policyholder benefits and claims 43,954 41,461 41,461
Interest credited to policyholder account balances 5,538 5,214 6,464
Policyholder dividends 876 1,090 1,211
Other expenses 12,586 13,150 13,689
Total expenses 62,954 60,915 62,825
Income (loss) before provision for income tax 8,126 6,927 6,795
Provision for income tax expense (benefit) 1,551 1,509 886
Net income (loss) 6,575 5,418 5,909
Less: Net income (loss) attributable to noncontrolling interests 21 11 10
Net income (loss) attributable to MetLife, Inc. 6,554 5,407 5,899
Less: Preferred stock dividends 195 202 178
Preferred stock redemption premium 6 14 0
Net income (loss) available to MetLife, Inc.’s common shareholders $ 6,353 $ 5,191 $ 5,721
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:      
Basic $ 7.36 $ 5.72 $ 6.10
Diluted $ 7.31 $ 5.68 $ 6.06